Latest filings (excl ownership)
6-K
Current report (foreign)
16 Aug 24
25-NSE
Exchange delisting
19 Jul 24
6-K
Aesthetic Medical International Holdings Group Ltd. Announces the Commencement of OTCQX Trading
10 Jul 24
6-K
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel
20 May 24
6-K
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing
25 Apr 24
20-F
2023 FY
Annual report (foreign)
25 Apr 24
6-K
Current report (foreign)
8 Mar 24
6-K
Aesthetic Medical International Announces Change of Auditor and Change of Director
12 Dec 23
UPLOAD
Letter from SEC
16 Oct 23
20-F/A
2022 FY
Annual report (foreign) (amended)
22 Sep 23
6-K
Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
8 Sep 23
6-K
Aesthetic Medical International Reports First Half of 2023 Unaudited Financial Results
5 Sep 23
CORRESP
Correspondence with SEC
5 Sep 23
UPLOAD
Letter from SEC
22 Aug 23
6-K
Current report (foreign)
17 Aug 23
CORRESP
Correspondence with SEC
3 Aug 23
UPLOAD
Letter from SEC
21 Jul 23
RW
Registration withdrawal request
23 May 23
6-K
Aesthetic Medical International Reports First Quarter 2023 Unaudited Financial Results
17 May 23
20-F
2022 FY
Annual report (foreign)
21 Apr 23
6-K
Current report (foreign)
16 Feb 23
6-K
Current report (foreign)
19 Jan 23
6-K
Current report (foreign)
6 Dec 22
6-K
Aesthetic Medical International Reports Third Quarter 2022 Unaudited Financial Results
29 Nov 22
6-K
Current report (foreign)
8 Sep 22
6-K
Aesthetic Medical International Reports First Half of 2022 Unaudited Financial Results
17 Aug 22
6-K
Current report (foreign)
2 Aug 22
6-K
Current report (foreign)
20 Jul 22
6-K
Aesthetic Medical International Announced Closing of RMB100 Million Private Placement
14 Jul 22
6-K
Aesthetic Medical International Reports First Quarter 2022 Unaudited Financial Results
29 Jun 22
F-3
Shelf registration (foreign)
17 Jun 22
6-K
Aesthetic Medical International and Investors Entered into an Amendment to a Share Subscription Agreement
31 May 22
20-F
2021 FY
Annual report (foreign)
16 May 22
6-K
Aesthetic Medical International Reports Fiscal Year 2021 Unaudited Financial Results
13 May 22
NT 20-F
Notice of late annual filing (foreign)
29 Apr 22
6-K
Aesthetic Medical International Announces Medical Risk Control System Upgrade to Support Healthy Development of the Aesthetic Medical Industry
17 Mar 22
6-K
Aesthetic Medical International Announces Change of Board Members and Committee Composition
18 Feb 22
6-K
Aesthetic Medical International Holdings Group Limited Announces Change in Certified Public Accountant
28 Jan 22
6-K
Aesthetic Medical International Announces Business Updates on Newly-acquired Non-surgical Business in Guangzhou
6 Dec 21
6-K
Aesthetic Medical International Announces Business Updates
2 Dec 21
Latest ownership filings
SC 13D/A
Peak Asia Investment Holdings V Ltd
17 Aug 23
SC 13D/A
Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)
17 Aug 23
SC 13D/A
Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)
24 Feb 23
SC 13D/A
Peak Asia Investment Holdings V Ltd
29 Jul 22
SC 13D
Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)
29 Jul 22
SC 13D
Zhou Pengwu
29 Jul 22
SC 13D
Ding Wenting
29 Jul 22
SC 13D/A
Hainan Runming Biotechnology Co., Ltd.
14 Jul 22
SC 13D
Hainan Runming Biotechnology Co., Ltd.
10 Jun 22
SC 13G/A
IDG-Accel China Growth Fund III L.P.
28 Feb 22
SC 13G
IDG-Accel China Growth Fund III L.P.
28 Feb 22
SC 13G/A
Zhou Pengwu
24 May 21
SC 13D
Peak Asia Investment Holdings V Ltd
22 Sep 20
SC 13G
Peak Asia Investment Holdings V Ltd
21 Apr 20
SC 13G
Aesthetic Medical International Holdings Group Ltd
4 Mar 20
SC 13G
Beneficial ownership report
4 Mar 20